GOLGA2P11

Across TCGA pan-cancer cohorts, GOLGA2P11 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated GOLGA2P11 data layer compared with 1 for mutation status.

The strongest signal is observed in uveal melanoma (UVM), where higher GOLGA2P11 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GOLGA2P11 expression acts as an unfavorable survival marker, although some lineages such as CESC and LAML show a favorable association.

UVM, CESC, and READ are the cancer types where GOLGA2P11 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.188	0.780	<.001	144	view →
CESC	OS	Tertile	All	0.883	0.513	<.001	54	view →
READ	DFS	Tertile	All	0.470	0.724	.015	33	view →
ACC	DFS	Tertile	All	0.471	0.705	.005	33	view →
KICH	OS	Tertile	III,IV	0.178	0.847	<.001	27	view →
UCS	DFS	Median	All	0.237	0.532	.015	24	view →
LAML	DFS	Quartile	All	0.543	0.279	.006	22	view →
LGG	DFS	Tertile	All	0.240	0.440	.003	21	view →
COAD	OS	Tertile	III,IV	0.185	0.711	.003	18	view →
TGCT	DFS	Tertile	All	0.915	0.713	.007	16	view →
LUSC	DFS	Tertile	All	0.677	0.780	.007	13	view →
SKCM	DFS	Tertile	IV	0.042	0.471	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

GOLGA2P11–UVM (DFS)

Open the UVM breakdown →